Daily Hand-Held Vibration Therapy
Part of paid clinical trials in Avon, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT04207437
- Status
- Recruiting
Conditions
- Cancer
- Chemotherapeutic Drug - Induced Nephropathy
- Chemotherapeutic Toxicity
- Neuropathy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Vibration therapy — DEVICEvibration therapy using hand held vibration device
Study Details
The purpose of this pilot study is to determine the safety and feasibility of a daily 3-minute hand-held vibration therapy intervention to reduce the severity of CIPN in the hands. The investigators hypothesize that daily vibration therapy can reduce the severity of patient's CIPN in their hands and improve CIPN-related quality of life. The hope is that results from this study will provide early data on the feasibility, efficacy, and most importantly, safety, of daily 3-minute hand-held vibration therapy needed to justify future clinical trials examining vibration therapy as a potential option for treating CIPN in the future.
Key Dates
- Start date
- Dec 6, 2021
- Status verified
- May 2026
- Primary completion
- Sep 30, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 16 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Vibration TherapyPatients will hold a hand held vibrating device for 3 minutes on each hand daily for 4 weeks.
Primary Outcome Measure
Feasibility of recruitment- percentage of patients who agree to participate in the study after screening [ Time Frame: recruitment period (up to 5 year after study starts) ]
Central Contacts
- Cheri West, RN317-278-3021
- Lacy Slayton(317) 278-6718
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Indiana University Health West | Avon | Indiana | 46123 | |
| Indiana University Melvin & Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | |
| IU Health Joe & Shelly Schwarz Cancer Center | Indianapolis | Indiana | 46202 |
Find similar trials in Avon, IN
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid TumorsPHASE1 · Recruiting · Shenzhen Ionova Life Sciences Co., Ltd. · Lafayette, Indiana
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPHASE1 · Recruiting · Tizona Therapeutics, Inc · Tucson, Arizona
- Measuring the Impact of Onco4D® Guidance on Chemotherapy Selection and OutcomesNot Yet Recruiting · Animated Dynamics, Inc. · Indianapolis, Indiana